Sana Biotechnology Faces Shareholder Lawsuit Over Alleged Misleading StatementsMarch 24, 2025 A shareholder has filed a class action lawsuit against Seattle-based Sana Biotechnology Inc., alleging the company misrepresented its capabilities in developing genetic therapies.